Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression. (2013)
Attributed to:
Establishment of the haemopoietic transcriptional programme: From systems approaches to molecular mechanisms
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/mcb.01525-12
PubMed Identifier: 23319051
Publication URI: http://europepmc.org/abstract/MED/23319051
Type: Journal Article/Review
Volume: 33
Parent Publication: Molecular and cellular biology
Issue: 6
ISSN: 0270-7306